{"@context":"https://schema.org","@type":"Article","headline":"Part 2 multiple-enrollment disclosure trigger","description":"Learn the Part 2 events that permit a multiple-enrollment disclosure: treatment acceptance, medication change, interruption, resumption, or termination.","url":"https://finnihealth.com/resources/glossary/part-2-multiple-enrollment-disclosure-trigger","datePublished":"2026-08-17T00:00:00.000Z","dateModified":"2026-08-24T00:00:00.000Z","author":{"@type":"Organization","name":"Finni Health Editorial Team"},"publisher":{"@type":"Organization","name":"Finni Health","url":"https://www.finnihealth.com"},"isPartOf":{"@type":"CollectionPage","name":"ABA and Practice Operations Glossary","url":"https://www.finnihealth.com/resources/glossary"},"breadcrumb":{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Resources","item":"https://www.finnihealth.com/resources"},{"@type":"ListItem","position":2,"name":"Glossary","item":"https://www.finnihealth.com/resources/glossary"},{"@type":"ListItem","position":3,"name":"Part 2 multiple-enrollment disclosure trigger","item":"https://finnihealth.com/resources/glossary/part-2-multiple-enrollment-disclosure-trigger"}]}}
Glossary term

Part 2 multiple-enrollment disclosure trigger

Learn the Part 2 events that permit a multiple-enrollment disclosure: treatment acceptance, medication change, interruption, resumption, or termination.

5
min read
Updated
August 23, 2026
Sources checked
August 23, 2026
· View sources
Also called

acceptance dosage change interruption disclosure SUD enrollment event trigger

A Part 2 trigger for a multiple-enrollment disclosure is one of the events in 42 CFR 2.34: the patient is accepted for treatment; the type or dosage of the drug changes; or treatment is interrupted, resumed, or terminated. The event opens a review. It does not authorize an automatic transmission because program type, recipient, distance where applicable, consent, data scope, and purpose must also qualify.

Editorial approval scope: The team checked current source fidelity, scope boundaries, dates, arithmetic, reader usefulness, practical workflow, and general-information limitations.

Current rule checkpoint

Live 42 CFR 2.34(a)(1) lists the events that can support a multiple-enrollment disclosure: treatment acceptance; a change in the type or dosage of the drug; or treatment interruption, resumption, or termination. Each event starts a release review. None removes the separate requirements for qualifying recipient, consent, distance where applicable, limited content, and purpose.

Use event-specific states

Current § 2.34(a)(1) identifies five operational states. Define accepted, changed, interrupted, resumed, and terminated for the actual program, including responsible role, source record, timestamp, correction path, and effective event. Avoid inferring a trigger from an appointment edit alone.

Prevent duplicate and stale messages

Assign an event ID and version. Reconcile corrected dosage, reversed acceptance, same-day resumption, late documentation, duplicate interfaces, failed transmission, and retry. A retry of one disclosure should not look like a new clinical event.

Clinical authorship stays clinical

The HHS fact sheet does not assign clinical decisions to software or operations. A qualified clinician records the clinical state and medication change within scope. Privacy and operations roles verify the disclosure route.

Define each treatment state clinically

Create approved definitions for acceptance, medication-type change, dosage change, interruption, resumption, and termination in the actual program. Identify who can enter the state, which clinical or operational record is authoritative, when it becomes effective, and how corrections or reversals occur. Keep scheduling and billing states separate.

Use plain language in staff guidance so a missed visit, pending intake, refill, dose discussion, temporary hold, discharge plan, and completed termination are not collapsed into one trigger.

Capture an immutable event record

Record patient, program, event type, effective date and time, source, author, medication type and dosage where relevant, prior state, new state, reason where appropriate, version, and linked correction. Assign a stable event identifier that follows message creation, approval, transmission, retry, and acknowledgment.

Late entry should retain both the clinical effective time and documentation time. A corrected dosage or reversed acceptance should not leave the registry with an uncorrected state.

Prevent duplicate and stale transmission

Use idempotency, status checks, version comparison, retry logic, and reconciliation. Distinguish a failed attempt from a successful disclosure, a technical retry from a new clinical event, and a correction from an unrelated later change. Hold an event when consent or recipient data has expired while it waited.

Build alerts for out-of-order interruption and resumption, repeated termination, impossible dose changes, multiple open events, and acknowledgments that do not match the sent version.

Run the rest of the release gate

Before sending, verify Part 2 program status, central registry or qualifying program, 200-mile limit where relevant, current section 2.31 and 2.34 consent, patient identity, allowed payload, multiple-enrollment purpose, secure destination, approver, and evidence. An automated clinical trigger should create a review item rather than unconditional disclosure.

Clinical roles own the clinical state within their scope. Privacy and operations own legal and routing checks. Software can enforce fields and states but should not infer a clinical event from an appointment or claim alone.

Reconcile downstream state

Preserve the payload, transmission timestamp, recipient, acknowledgment, rejection, correction, and final registry or program disposition. Investigate mismatches before the next medication or treatment event. Keep a controlled manual path for downtime and back-enter it with original facts.

Audit candidate events as well as sent events. Measure correct trigger classification, duplicates prevented, corrections completed, consent and recipient holds, delivery, and unresolved mismatches.

Review trigger defects jointly with clinical and privacy owners. A missed or wrong event can create both confidentiality and medication-safety risk, so remediation should address the patient record, recipient state, interface logic, and staff process together.

Example

Seventeen candidate events enter the queue. Thirteen have a defined trigger, clinical source, timestamp, version, consent, recipient, and release decision; four are schedule cancellations without a treatment-state decision. Trigger accuracy is 13 of 17 events.

Treatment-event checklist

  • define the six listed states, authority, source, effective time, and correction path;
  • preserve patient, program, prior and new state, medication data, author, and version;
  • distinguish documentation time, clinical time, retry, correction, and new event;
  • require recipient, distance, consent, payload, purpose, security, and approval gates;
  • reconcile transmission, acknowledgment, rejection, correction, and downtime events; and
  • audit all candidates, including blocked, duplicate, stale, and misclassified events.

The trigger is a verified treatment-state change, not a generic activity signal. It opens a controlled release decision.

Related terms

Sources

Beyond the glossary

Take the next step with clarity

Whether you are finding care, growing as a clinician, or building a stronger ABA practice, Finni brings the people, tools, and support together to help you move forward.

Start or grow your ABA practice with Finni